FFCP PHASE2:Hg19::chr16:29674246..29674275,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p3@SPN |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_SPN_5end |
Coexpression cluster: | C3554_acute_myelodysplastic_Natural_chronic_Basophils_CD8_CD133 |
Association with transcript: | -24bp_to_ENST00000395389, NM_001030288, uc002dtm.2_5end |
EntrezGene: | SPN |
HGNC: | 11249 |
UniProt: | P16150A8K9B1 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p3@SPN |
---|
0
5
10
15
20
25
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 1.54e-48 | 168 |
hematopoietic cell | 4.99e-45 | 177 |
hematopoietic oligopotent progenitor cell | 8.99e-43 | 161 |
hematopoietic multipotent progenitor cell | 8.99e-43 | 161 |
T cell | 1.36e-29 | 25 |
pro-T cell | 1.36e-29 | 25 |
lymphoid lineage restricted progenitor cell | 1.19e-27 | 52 |
lymphocyte | 5.96e-27 | 53 |
common lymphoid progenitor | 5.96e-27 | 53 |
mature alpha-beta T cell | 1.30e-24 | 18 |
Showing 1 to 10 of 32 entries
Ontology term | p-value | n |
---|---|---|
blood | 5.20e-14 | 15 |
haemolymphatic fluid | 5.20e-14 | 15 |
organism substance | 5.20e-14 | 15 |
connective tissue | 3.53e-11 | 371 |
hematopoietic system | 1.81e-08 | 98 |
blood island | 1.81e-08 | 98 |
hemolymphoid system | 1.07e-07 | 108 |
Showing 1 to 7 of 7 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 2.82e-43 | 39 |
hematologic cancer | 4.13e-40 | 51 |
immune system cancer | 4.13e-40 | 51 |
myeloid leukemia | 4.43e-39 | 31 |
organ system cancer | 1.81e-08 | 137 |
Showing 1 to 5 of 5 entries